title: The pharmacogenomics of clopidogrel.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Levitt
authors.forename: Joshua W
authors.initials: JW
authors.lastname: Osbun
authors.forename: Louis J
authors.initials: LJ
authors.lastname: Kim
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D010597:Pharmacogenetics; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology*; D019095:Point-of-Care Systems; D058925:Receptors, Purinergic P2Y12 / Q000235:genetics / Q000378:metabolism; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology
chemical_list: D010975:Platelet Aggregation Inhibitors; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine